clinical trial · NCT07032662
IMVT-1402 in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
Immunovant Sciences GmbH·phase2·recruiting·n = 162
Chronic Inflammatory Demyelinating PolyneuropathyIMVT-1402Placebo
brief summary
This is a Phase 2b study to evaluate the efficacy and safety of IMVT-1402 in adults with CIDP.
started
Mar 18, 2025
primary completion
Aug 1, 2028
completion
May 1, 2030
last updated
Apr 22, 2026
detailed description
This is a multi-center, randomized, double-blind, placebo-controlled study to evaluate the efficacy and safety of IMVT-1402 in adult participants with active CIDP.
official title
A Phase 2b, Multi-center, Randomized, Double-blind, Placebo-controlled Study of IMVT-1402 Treatment in Adult Participants With Chronic Inflammatory Demyelinating Polyneuropathy (CIDP)
sourced from ClinicalTrials.gov · pharmadog mirrors structured fields, not the full protocol